CC BY-NC-ND 4.0 · J Lab Physicians 2020; 12(04): 285-288
DOI: 10.1055/s-0040-1722548
Case Report

Morquio Syndrome Presenting with Dural Band Pathology: A Case Report

Saloni Gupta
1   Departments of Lab Medicine, Jai Prakash Narayan Apex Trauma Center, AIIMS, New Delhi, India
,
Kangana Sengar
1   Departments of Lab Medicine, Jai Prakash Narayan Apex Trauma Center, AIIMS, New Delhi, India
,
1   Departments of Lab Medicine, Jai Prakash Narayan Apex Trauma Center, AIIMS, New Delhi, India
,
Gurudatta Satyarthee
2   Departments of Neurosurgery, Jai Prakash Narayan Apex Trauma Center, AIIMS, New Delhi, India
› Author Affiliations

Abstract

Morquio syndrome is caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) enzyme, which is required for the catabolism of glycosaminoglycans (namely, chondroitin-6-sulfate and keratan sulfate). Pathogenic accumulation of these glycosaminoglycans occurs throughout the body. The various organs and tissues affected are bones, cartilage, tendon, teeth, trachea and lungs, heart, cornea, skin and connective tissues.

Here, we present a case of Morquio syndrome. A 16-year-old boy presented with multiple skeletal abnormalities, including cervicomedullary compression by dorsal dural band in foramen magnum. The dural band was resected during the surgery to relieve compression and sent for histopathological examination. This case report not only reviews the clinical features and shows rare dural band histopathological findings but also mentions a note on the future therapies of this syndrome.



Publication History

Article published online:
30 December 2020

© 2020. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver C.R.F, Beaudet A.L.. W.S., Valle D. eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001: 3421-3452
  • 2 Tomatsu S, Orii KO, Vogler C. et al. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet 2003; 12 (24) 3349-3358
  • 3 Tomatsu S, Gutierrez M, Nishioka T. et al. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum Mol Genet 2005; 14 (22) 3321-3335
  • 4 Tomatsu S, Vogler C, Montaño AM. et al. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins. Mol Genet Metab 2007; 91 (03) 251-258
  • 5 Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 2007; 30 (02) 165-174
  • 6 Tomatsu S, Montaño AM, Oikawa H. et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 2011; 12 (06) 931-945
  • 7 Tomatsu S, Mackenzie WG, Theroux MC. et al. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review. Res Rep Endocr Disord 2012; 2012 (02) 65-77
  • 8 Mopagar VS, Kathariya MD, Umapathy T, Premkishore K. Morquios syndrome: A rare case report. J Indian Acad Oral Med Radiol 2013; 25: 63-65
  • 9 Khan SA, Peracha H, Ballhausen D. et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab 2017; 121 (03) 227-240
  • 10 Hollister DW, Cohen AH, Rimoin DL, Silberberg R. The Morquio syndrome (mucopolysaccharidosis IV): Morphologic and biochemical studies. Johns Hopkins Med J 1975; 137 (04) 176-183
  • 11 Couprie J, Denis P, Guffon N, Reynes N, Masset H, Beby F. Manifestations ophtalmologiques de la maladie de Morquio. [Ocular manifestations in patients affected by Morquio syndrome (MPS IV)] J Fr Ophtalmol 2010; 33 (09) 617-622
  • 12 Peracha H, Sawamoto K, Averill L. et al. Molecular genetics and metabolism, special edition: diagnosis and prognosis of mucopolysaccharidosis IVA. Mol Genet Metab 2018; 125 (1-2) 18-37
  • 13 Braunlin EA, Harmatz PR, Scarpa M. et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis 2011; 34 (06) 1183-1197
  • 14 Boffi L, Russo P, Limongelli G. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists. Ital J Pediatr 2018; 44 (Suppl. 02) 122
  • 15 Hendriksz CJ, Al-Jawad M, Berger KI. et al. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 2013; 36 (02) 309-322
  • 16 De Franceschi L, Roseti L, Desando G, Facchini A, Grigolo B. A molecular and histological characterization of cartilage from patients with Morquio syndrome. Osteoarthritis Cartilage 2007; 15 (11) 1311-1317
  • 17 Bank RA, Groener JE, van Gemund JJ. et al. Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients. Mol Genet Metab 2009; 97 (03) 196-201
  • 18 Matalon R, Arbogast B, Dorfman A. Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome. Biochem Biophys Res Commun 1974; 61 (04) 1450-1457
  • 19 O’Brien JS, Gugler E, Giedion A. et al. Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency. Clin Genet 1976; 9 (05) 495-504
  • 20 McKusick VA. Heritable Disorders of Connective Tissue. 4th ed. St. Louis: Mosby C.V; 1972
  • 21 Maccari F, Galeotti F, Zampini L. et al. Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3days of age for early diagnosis application. Clin Chim Acta 2016; 463: 67-72
  • 22 Rekka P, Rathna PV, Jagadeesh S, Seshadri S. Mucopolysaccharidoses type IV A (Morquio syndrome): a case series of three siblings. J Indian Soc Pedod Prev Dent 2012; 30 (01) 66-69
  • 23 Kalteis T, Schubert T, Caro WC, Schröder J, Lüring C, Grifka J. Arthroscopic and histologic findings in Morquio’s syndrome. Arthroscopy 2005; 21 (02) 233-237
  • 24 Yasuda E, Fushimi K, Suzuki Y. et al. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol Genet Metab 2013; 109 (03) 301-311
  • 25 Doherty C, Averill LW, Theroux M. et al. Natural history of Morquio A patient with tracheal obstruction from birth to death. Mol Genet Metab Rep 2017; 14: 59-67
  • 26 Biswas SN, Patra S, Chakraborty PP, Barman H. Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia. BMJ Case Rep 2017; 2017: bcr-2017-221156
  • 27 Choudhury I, Tilak MA, Patra AK. A rare case of mucopolysaccharidosis. Indian J Clin Biochem 2014; 29 (01) 101-106